The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Hideki Fujino

Tokyo Research Laboratories

Kowa Company Ltd.

Higashimurayama

Tokyo

Japan

[email]@kowa.co.jp

Name/email consistency: high

 
 
 
 
 
 
 

Affiliation

  • Tokyo Research Laboratories, Kowa Company Ltd., Higashimurayama, Tokyo, Japan. 2002 - 2005

References

  1. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase. Fujino, H., Saito, T., Ogawa, S., Kojima, J. J. Pharm. Pharmacol. (2005) [Pubmed]
  2. Effect of gemfibrozil on the metabolism of pitavastatin--determining the best animal model for human CYP and UGT activities. Fujino, H., Saito, T., Tsunenari, Y., Kojima, J. Drug. Metabol. Drug. Interact (2004) [Pubmed]
  3. Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase. Fujino, H., Nakai, D., Nakagomi, R., Saito, M., Tokui, T., Kojima, J. Arzneimittelforschung (2004) [Pubmed]
  4. Metabolic properties of the acid and lactone forms of HMG-CoA reductase inhibitors. Fujino, H., Saito, T., Tsunenari, Y., Kojima, J., Sakaeda, T. Xenobiotica (2004) [Pubmed]
  5. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization. Fujino, H., Yamada, I., Shimada, S., Yoneda, M., Kojima, J. Xenobiotica (2003) [Pubmed]
  6. Interaction between several medicines and statins. Fujino, H., Saito, T., Tsunenari, Y., Kojima, J. Arzneimittelforschung (2003) [Pubmed]
  7. Studies on the interaction between fibrates and statins using human hepatic microsomes. Fujino, H., Shimada, S., Yamada, I., Hirano, M., Tsunenari, Y., Kojima, J. Arzneimittelforschung (2003) [Pubmed]
  8. Interaction between fibrates and statins--metabolic interactions with gemfibrozil. Fujino, H., Yamada, I., Shimada, S., Hirano, M., Tsunenari, Y., Kojima, J. Drug. Metabol. Drug. Interact (2003) [Pubmed]
  9. Metabolic fate of pitavastatin (NK-104), a new inhibitor of 3-hydroxy-3-methyl-glutaryl coenzyme A reductase. Effects on drug-metabolizing systems in rats and humans. Fujino, H., Yamada, I., Shimada, S., Nagao, T., Yoneda, M. Arzneimittelforschung (2002) [Pubmed]
  10. Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase--effect of cMOAT deficiency on hepatobiliary excretion in rats and of mdr1a/b gene disruption on tissue distribution in mice. Fujino, H., Yamada, I., Shimada, S., Kojima, J. Drug Metab. Pharmacokinet. (2002) [Pubmed]
 
WikiGenes - Universities